NMCAX
Price
$19.90
Change
+$0.21 (+1.07%)
Updated
Oct 8 closing price
Net Assets
713.49M
RPMGX
Price
$103.51
Change
+$1.25 (+1.22%)
Updated
Oct 8 closing price
Net Assets
26.68B
Interact to see
Advertisement

NMCAX vs RPMGX

Header iconNMCAX vs RPMGX Comparison
Open Charts NMCAX vs RPMGXBanner chart's image
Voya MidCap Opportunities A
Price$19.90
Change+$0.21 (+1.07%)
VolumeN/A
Net Assets713.49M
T. Rowe Price Mid-Cap Growth
Price$103.51
Change+$1.25 (+1.22%)
VolumeN/A
Net Assets26.68B
NMCAX vs RPMGX Comparison Chart in %
View a ticker or compare two or three
VS
NMCAX vs. RPMGX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NMCAX is a Buy and RPMGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPMGX has more cash in the bank: 26.7B vs. NMCAX (713M). NMCAX (0.00) and RPMGX (0.00) have matching dividends . NMCAX was incepted earlier than RPMGX: NMCAX (27 years) vs RPMGX (33 years). NMCAX (1.25) is less costly to investors than RPMGX (0.75). NMCAX is a more actively managed with annual turnover of: 87.00 vs. RPMGX (22.60). NMCAX has a lower initial minimum investment than RPMGX: NMCAX (1000) vs RPMGX (2500). NMCAX annual gain was more profitable for investors over the last year : 2.39 vs. RPMGX (-5.53). RPMGX return over 5 years is better than : -4.29 vs. NMCAX (-20.35).
NMCAXRPMGXNMCAX / RPMGX
Total Expense Ratio1.250.75167%
Annual Report Gross Expense Ratio1.250.75167%
Fund Existence27 years33 years-
Gain YTD8.1272.537320%
Front Load6%N/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets713M26.7B3%
Annual Yield % from dividends0.000.00-
Returns for 1 year2.39-5.53-43%
Returns for 3 years36.4519.23190%
Returns for 5 years-20.35-4.29474%
Returns for 10 years-13.1528.82-46%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BBP72.160.53
+0.75%
Virtus LifeSci Biotech Products ETF
JCPB47.450.04
+0.08%
JPMorgan Core Plus Bond ETF
KCE151.180.10
+0.07%
SPDR® S&P Capital Markets ETF
IBDZ26.44-0.01
-0.04%
iShares iBonds Dec 2034 Term Corp ETF
SCJ90.90-0.53
-0.58%
iShares MSCI Japan Small-Cap ETF